RhumbLine Advisers’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

RhumbLine Advisers’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-172,921	Closed	-$2.93M	–	3066
2014 Q4	$2.93M	Buy	172,921 +26,665	+18%	+$375K	0.01%	1111
2014 Q3	$1.74M	Buy	146,256 +1,615	+1%	+$11K	0.01%	1417
2014 Q2	$816K	Buy	144,641 +3,711	+3%	+$17.1K	﹤0.01%	1959
2014 Q1	$517K	Sell	140,930 -7,080	-5%	-$27K	﹤0.01%	2207
2013 Q4	$497K	Sell	148,010 -6,600	-4%	-$27.3K	﹤0.01%	2261
2013 Q3	$656K	Sell	154,610 -102	-0.1%	-$483	﹤0.01%	2043
2013 Q2	$712K	Buy	+154,712	New	+$532K	﹤0.01%	1990

RhumbLine Advisers's AVNR Position: Q1 2015 in Review

RhumbLine Advisers sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 172,921 shares — an estimated $2.93M sold.

RhumbLine Advisers first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $2.93M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

RhumbLine Advisers reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
RhumbLine Advisers sold 172,921 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.93M.
RhumbLine Advisers first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
RhumbLine Advisers's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.93M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.